ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.64
      1.08%
      US Tech 100
      19,320.00
      1.63%
      Dow Jones
      40,407.97
      0.30%
      Brent Oil
      81.615
      -0.81%
      Bitcoin
      67,523.43
      -0.93%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Sanofi (SAN) Quote

      Sanofi

      Sanofi (SAN)

      Sagalio Energy Ltd
      Sant Uk.10te%
      Banco Santander SA
      93.50
      1.14
      (1.23%)
      Closed July 22 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      93.50
      Bid
      93.35
      Ask
      94.00
      Volume
      1,602,353
      92.79 Day's Range 94.33
      80.60 52 Week Range 104.32
      Market Cap
      115.694B
      Previous Close
      92.36
      Open
      93.20
      Last Trade
      3310
      @
      93.5
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,484,394
      Shares Outstanding
      1,252,640,466
      Dividend Yield
      8.04%
      PE Ratio
      21.69
      Earnings Per Share (EPS)
      4.31
      Revenue
      43.07B
      Net Profit
      5.4B

      About Sanofi

      Sector
      Health & Allied Services,nec
      Industry
      Pharmaceutical Preparations
      Website
      www.sanofi.com
      Headquarters
      Paris, Paris, Fra
      Founded
      1994
      Sanofi is listed in the Health & Allied Services sector of the Euronext with ticker SAN. The last closing price for Sanofi was 92.36 €. Over the last year, Sanofi shares have traded in a share price range of 80.60 € to 104.32 €.

      Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 115.69 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.69.

      SAN Latest News

      More News

      Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A

         NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A ALTUVIIIO provides high-sustained factor...

      July 17 2024
      GlobeNewswire Inc.

      Communiqué de presse : Le NEJM publie les données de phase III de l’étude XTEND-Kids montrant qu’ALTUVIIIO a le potentiel de transformer la prise en charge thérapeutique des enfants atteints d’hémophilie A sévère

      Communiqué de presse : Le NEJM publie les données de phase III de l’étude XTEND-Kids montrant qu’ALTUVIIIO a le potentiel de transformer la prise en charge thérapeutique des enfants atteints...

      July 17 2024
      UK Regulatory

      Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD

      Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on...

      July 03 2024
      GlobeNewswire Inc.

      Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne

      Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne Dupixent devient le tout premier médicament ciblé pour...

      July 03 2024
      GlobeNewswire Inc.

      Communiqué de presse : Publication dans le NEJM des données positives de phase III du Dupixent dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 12 mois à 11 ans

      Communiqué de presse : Publication dans le NEJM des données positives de phase III du Dupixent dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 12 mois à 11 ans...

      June 26 2024
      GlobeNewswire Inc.

      Press Release: Availability of the Q2 2024 Aide-mémoire

      Press Release: Availability of the Q2 2024 Aide-mémoire Availability of the Q2 2024 Aide-mémoire Paris, France – June 25, 2024. Sanofi announced that its Q2 2024 Aide-mémoire is available on...

      June 25 2024
      GlobeNewswire Inc.

      Communiqué de presse : Mise en ligne du document « Aide-mémoire Q2 2024 »

      Communiqué de presse : Mise en ligne du document « Aide-mémoire Q2 2024 » Mise en ligne du document « Aide-mémoire Q2 2024 » Paris, France, le 25 juin 2024. Sanofi annonce la mise en ligne...

      June 25 2024
      GlobeNewswire Inc.

      Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee

      Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee Audrey Duval Derveloy appointed Global Head of Corporate Affairs...

      June 21 2024
      GlobeNewswire Inc.

      Communiqué de presse : Audrey Duval Derveloy nommée Directrice Affaires Corporate Groupe, membre du Comité exécutif de Sanofi

      Communiqué de presse : Audrey Duval Derveloy nommée Directrice Affaires Corporate Groupe, membre du Comité exécutif de Sanofi Audrey Duval Derveloy nommée Directrice Affaires Corporate...

      June 21 2024
      GlobeNewswire Inc.

      Communiqué de presse : ISTH : De nouvelles données sur ALTUVIIIO et le fitusiran confortent le leadership de Sanofi dans le traitement de l’hémophilie

      Communiqué de presse : ISTH : De nouvelles données sur ALTUVIIIO et le fitusiran confortent le leadership de Sanofi dans le traitement de l’hémophilie   ISTH : De nouvelles données sur...

      June 21 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.41-0.43658822276693.9194.3390.73120263292.19915345DE
      45.466.2017264879688.0494.9187.53143462191.57856397DE
      121.842.0074187213691.6694.9185.94148439490.51694693DE
      26-0.21-0.22409561412993.7194.9184.93144280089.52601039DE
      52-5.43-5.4887294046398.93104.3280.6146095991.38323891DE
      1566.57.4712643678287106.6676.45178134191.37036362DE
      26018.524.666666666775106.6667.65201001888.07411886DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MIRAMIRA Pharmaceuticals Inc
      $ 3.5699
      (418.28%)
      		136.28M
      CMAXCareMax Inc
      $ 5.185
      (228.16%)
      		89.84M
      NUKKNukkleus Inc
      $ 0.46
      (43.75%)
      		21.25M
      LPSNLivePerson Inc
      $ 1.29
      (30.30%)
      		7.17M
      SNOASonoma Pharmaceuticals Inc
      $ 0.3945
      (28.08%)
      		3.3M
      LGCBLinkage Global Inc
      $ 3.66
      (-29.82%)
      		160.1k
      CGBSCrown LNG Holdings Ltd
      $ 0.9901
      (-29.78%)
      		3M
      IVPInspire Veterinary Partners Inc
      $ 9.00
      (-23.40%)
      		875.78k
      SLNASelina Hospitality PLC
      $ 0.036307
      (-23.24%)
      		64.43M
      NNENano Nuclear Energy Inc
      $ 14.83
      (-23.16%)
      		1.36M
      NVDANVIDIA Corporation
      $ 123.26
      (4.52%)
      		189.1M
      SQQQProShares UltraPro Short QQQ
      $ 8.0602
      (-4.73%)
      		154.93M
      MIRAMIRA Pharmaceuticals Inc
      $ 3.5591
      (416.71%)
      		136.29M
      SERVServe Robotics Inc
      $ 9.16
      (21.32%)
      		133.02M
      NCPLNetcapital Inc
      $ 0.1108
      (6.54%)
      		117.42M

      Discussion

      View Full Feed
      4OurRetirement 4OurRetirement 5 minutes ago
      "Breakout trade WATCH for possible breakout above 25.81..."

      "Target: 29.05, 13.6% Stop: 24.47 Loss: 4.3%
      P/L ratio: 3.2 : 1 - Excellent"
      **************************
      At Least According To:
      https://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=GME
      GME
      Myth Myth 5 minutes ago
      Hard Times · Eric Clapton

      nice cover...

      https://www.youtube.com/watch?v=lHHTAcrrNE4
      prostock30 prostock30 5 minutes ago
      Let's go leaving trips soon $$$NWPN$$$
      NWPN
      JusDePomme JusDePomme 5 minutes ago
      88mil buy ask .0004.... Crazy flipper
      GRLT
      Huggy Bear Huggy Bear 5 minutes ago
      Perhaps our local friend will find out, and enjoy every minute of it.
      SPZI
      SSKILLZ1 SSKILLZ1 5 minutes ago
      Has anyone noticed. Edge still works, at least for me? All is just my opinion of course.
      rx7171 rx7171 5 minutes ago
      Kolbert joined EF Hutton just a week ago.
      Posting this new buy recommendation looks like he wants to hit the ground running at his new company.

      https://www.accesswire.com/viewarticle.aspx?id=888772
      AVXL
      MrSmithLWLG MrSmithLWLG 5 minutes ago
      = no deals by 12/31
      LWLG
      ProfitScout ProfitScout 5 minutes ago
      $CATV On The Brink Of Major Biotech Acquisition
      https://www.degenmag.com/post/catv-on-the-brink?fbclid=IwZXh0bgNhZW0CMTEAAR3JeK6FnTkxWKrJ_DGdNQIetrmaeLVZWu95CgJQbUnn4-kVcxLqS6KRYKk_aem_4HuKAP7r6qqO5vYOWbQGtA
      CATV
      Al 100 Al 100 6 minutes ago
      Squeeeeeze
      AMC
      StocktonCA StocktonCA 6 minutes ago
      nice paint job 1st thing in the morning. 4k shares. ha!!
      RSPI
      igotthemojo igotthemojo 6 minutes ago
      "We would like to add another 20,000 shares, before it turns around, going into 2025"

      how about waiting until its done dropping and waiting until it DOES turn around?...wait for this 4 yr long downtrend to turn postive?..

      look at a 4 year chart...there were some nice up
      PLUG
      ProfitScout ProfitScout 6 minutes ago
      $CATV On The Brink Of Major Biotech Acquisition
      https://www.degenmag.com/post/catv-on-the-brink?fbclid=IwZXh0bgNhZW0CMTEAAR3JeK6FnTkxWKrJ_DGdNQIetrmaeLVZWu95CgJQbUnn4-kVcxLqS6KRYKk_aem_4HuKAP7r6qqO5vYOWbQGtA
      CATV
      NeverShort NeverShort 6 minutes ago
      I couldn’t have said that better myself. Great post! Everybody needs to just sit back and let them do their job. We will be well rewarded.
      VPLM
      BERKSHIRE AGENT BERKSHIRE AGENT 6 minutes ago
      Prepping for lift off again Houston....
      HIRU
      ham n slam ham n slam 6 minutes ago
      one thing ive learned in 58yrs...(yes an old timer.) (yes the days of 12.00 concert tickets..)ones who wish harm upon others will face a scene /scenario i do not want to explain in this forum...be careful..hang tight
      VPLM
      gitreal gitreal 6 minutes ago
      LOL......you're back!? Did your scammer buddies renew your contract? Give in to your demands? You asked for cash, instead of restricted shares, didn't you!? I was wondering why the share price was inching upwards....now it is clear. You're back in the game ripping off gullible investors.....
      AABB
      RIGATONI RIGATONI 6 minutes ago
      Grabbed the 3s dip for the LOI closing late 3rd q ...

      The LOI outlines the key terms of the proposed merger, which values Primior at 30M and is expected to close in the late 3rd Quarter of 2024.






      ~Rig
      Monksdream Monksdream 7 minutes ago
      ADT new 52 week high
      https://investorshub.advfn.com/uimage/uploads/2024/7/22/kncpqIMG_9877.gif
      ADT
      redspinelpinktopaz redspinelpinktopaz 7 minutes ago
      We are way over due for a "tuesday-is-newsday"
      LWLG
      Involuntary-Recluse Involuntary-Recluse 7 minutes ago
      Yes, this applies to real RM attempts (AGBA,CLHI,WKSP etc etc etc) and numerous others that actually did try to do something.

      ;-)

      Unlike King 👑 tales from the phantom zone 😂


      imho.
      AGBA CLHI WKSP
      shermann7 shermann7 7 minutes ago
      Alasdair Macleod: This Gold Move Has Only Just Started - VIDEO

      https://www.youtube.com/watch?v=9JR0CBDmUSQ

      Shermann
      ANTI-BAGHOLDER ANTI-BAGHOLDER 7 minutes ago
      Really depends on the dilution…
      SINC
      Wayne R Wayne R 7 minutes ago
      If it isn't it probably should be
      HNRC

      Your Recent History

      EU
      SAN
      Sanofi
      FX
      BHDEUR
      BHD vs Euro
      FX
      RSDEUR
      RSD vs Euro
      FX
      PENBRL
      PEN vs BRL
      FX
      XPFUSD
      XPF vs US Dollar
      FX
      SVCGBP
      SVC vs Sterling
      FX
      COPEUR
      COP vs Euro
      FX
      CUPEUR
      CUP vs Euro
      FX
      USDTZS
      US Dollar vs TZS
      Delayed Upgrade Clock